• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸甘油酸激酶缺乏症中的肌病和帕金森病。

Myopathy and parkinsonism in phosphoglycerate kinase deficiency.

机构信息

Department of Neurology, Columbia University Medical Center, 3-313 Russ Berrie Medical Science Pavilion, 1150 St. Nicholas Avenue, New York, New York 10032, USA.

出版信息

Muscle Nerve. 2010 May;41(5):707-10. doi: 10.1002/mus.21612.

DOI:10.1002/mus.21612
PMID:20151463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8285082/
Abstract

A 25-year-old man with exertional myoglobinuria had no evidence of hemolytic anemia, but he had severe parkinsonism that was responsive to levodopa. Phosphoglycerate kinase (PGK) activity was markedly decreased in muscle, and molecular analysis of the PGK1 gene identified the p.T378P mutation that was recently reported in a patient with isolated myopathy. This case reinforces the concept that PGK deficiency is a clinically heterogeneous disorder and raises the question of a relationship between PGK deficiency and idiopathic juvenile Parkinson disease.

摘要

一位 25 岁的劳力性肌红蛋白尿患者没有溶血性贫血的证据,但他有严重的帕金森病,对左旋多巴有反应。肌肉中磷酸甘油酸激酶 (PGK) 活性明显降低,PGK1 基因突变的分子分析发现了最近报道的患有孤立性肌病的患者中的 p.T378P 突变。该病例进一步证实了 PGK 缺乏症是一种临床表现多样的疾病,并提出了 PGK 缺乏症与特发性青少年帕金森病之间的关系问题。

相似文献

1
Myopathy and parkinsonism in phosphoglycerate kinase deficiency.磷酸甘油酸激酶缺乏症中的肌病和帕金森病。
Muscle Nerve. 2010 May;41(5):707-10. doi: 10.1002/mus.21612.
2
Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations.磷酸甘油酸激酶(PGK)缺乏症的肌病形式:1例新病例及致病因素分析
Neuromuscul Disord. 2009 Mar;19(3):207-11. doi: 10.1016/j.nmd.2008.12.004. Epub 2009 Jan 20.
3
Phosphoglycerate kinase deficiency myopathy: biochemical and immunological studies of the mutant enzyme.磷酸甘油酸激酶缺乏性肌病:突变酶的生化与免疫学研究
Muscle Nerve. 1984 Sep;7(7):542-51. doi: 10.1002/mus.880070705.
4
Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation.磷酸甘油酸激酶缺乏症:一种具有新突变的成人肌病形式。
Neurology. 2000 Mar 14;54(5):1188-90. doi: 10.1212/wnl.54.5.1188.
5
Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction.PGK1 缺乏症中的帕金森病提示糖酵解途径在黑质纹状体功能障碍中的作用。
Parkinsonism Relat Disord. 2019 Jul;64:319-323. doi: 10.1016/j.parkreldis.2019.04.004. Epub 2019 Apr 5.
6
Phosphoglycerate kinase deficiency: biochemical and molecular genetic studies in a new myopathic variant (PGK Alberta).
Neurology. 1993 Feb;43(2):387-91. doi: 10.1212/wnl.43.2.387.
7
Phosphoglycerate kinase deficiency: A nationwide multicenter retrospective study.磷酸甘油酸激酶缺乏症:一项全国多中心回顾性研究。
J Inherit Metab Dis. 2019 Sep;42(5):803-808. doi: 10.1002/jimd.12087. Epub 2019 Apr 8.
8
A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization.一种新的磷酸甘油酸激酶缺乏症(p.I371K)变异体,具有多种组织受累:分子和功能特征。
Mol Genet Metab. 2012 Aug;106(4):455-61. doi: 10.1016/j.ymgme.2012.05.015. Epub 2012 May 30.
9
Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiency.残余酶活性水平调节磷酸甘油酸激酶缺乏症的表型。
Neurology. 2018 Sep 11;91(11):e1077-e1082. doi: 10.1212/WNL.0000000000006165. Epub 2018 Aug 15.
10
A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina).磷酸甘油酸激酶缺乏症(PGK北卡罗来纳州型)一种新的肌病性变异型中的剪接连接突变。
Ann Neurol. 1994 Mar;35(3):349-53. doi: 10.1002/ana.410350316.

引用本文的文献

1
Parkinson's disease and glucose metabolism impairment.帕金森病与葡萄糖代谢障碍。
Transl Neurodegener. 2025 Feb 17;14(1):10. doi: 10.1186/s40035-025-00467-8.
2
Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage.膀胱癌中的淀粉样蛋白会劫持与癌症相关的蛋白质,并且与肿瘤分期呈正相关。
Sci Rep. 2025 Feb 5;15(1):4393. doi: 10.1038/s41598-025-88307-7.
3
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.2型糖尿病对帕金森病病因的影响。
Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358.
4
Glycogen storage diseases.糖原贮积病。
Nat Rev Dis Primers. 2023 Sep 7;9(1):46. doi: 10.1038/s41572-023-00456-z.
5
A Mild Clinical Phenotype with Myopathic and Hemolytic Forms of Phosphoglycerate Kinase Deficiency (PGK Osaka): A Case Report and Literature Review.磷酸甘油酸激酶缺乏症(PGK 大阪型)的肌病和溶血性两种临床表现:病例报告及文献复习。
Intern Med. 2022 Dec 1;61(23):3589-3594. doi: 10.2169/internalmedicine.9221-21. Epub 2022 May 7.
6
Cerebroventricular Injection of Pgk1 Attenuates MPTP-Induced Neuronal Toxicity in Dopaminergic Cells in Zebrafish Brain in a Glycolysis-Independent Manner.脑室内注射 Pgk1 以非糖酵解依赖的方式减弱 MPTP 诱导的斑马鱼脑多巴胺能细胞的神经元毒性。
Int J Mol Sci. 2022 Apr 8;23(8):4150. doi: 10.3390/ijms23084150.
7
Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases.与阿尔茨海默病和帕金森病临床特征相关的脑功能代谢特征。
Molecules. 2022 Jan 30;27(3):951. doi: 10.3390/molecules27030951.
8
Glycolytic Metabolism, Brain Resilience, and Alzheimer's Disease.糖酵解代谢、脑弹性与阿尔茨海默病
Front Neurosci. 2021 Apr 28;15:662242. doi: 10.3389/fnins.2021.662242. eCollection 2021.
9
Towards Central Nervous System Involvement in Adults with Hereditary Myopathies.遗传性肌病患者的中枢神经系统受累。
J Neuromuscul Dis. 2020;7(4):367-393. doi: 10.3233/JND-200507.
10
Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases.增强糖酵解可减轻帕金森病模型和临床数据库中的疾病进展。
J Clin Invest. 2019 Oct 1;129(10):4539-4549. doi: 10.1172/JCI129987.

本文引用的文献

1
Mutations for Gaucher disease confer high susceptibility to Parkinson disease.戈谢病的突变会使人对帕金森病高度易感。
Arch Neurol. 2009 May;66(5):571-6. doi: 10.1001/archneurol.2009.72.
2
Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations.磷酸甘油酸激酶(PGK)缺乏症的肌病形式:1例新病例及致病因素分析
Neuromuscul Disord. 2009 Mar;19(3):207-11. doi: 10.1016/j.nmd.2008.12.004. Epub 2009 Jan 20.
3
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.葡萄糖脑苷脂酶基因突变与早发性帕金森病相关。
Neurology. 2007 Sep 18;69(12):1270-7. doi: 10.1212/01.wnl.0000276989.17578.02.
4
PGK deficiency.磷酸甘油酸激酶缺乏症
Br J Haematol. 2007 Jan;136(1):3-11. doi: 10.1111/j.1365-2141.2006.06351.x.
5
Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain.来自西班牙的两名患者中发现两个与慢性溶血性贫血和神经功能障碍相关的新磷酸甘油酸激酶突变。
Br J Haematol. 2006 Feb;132(4):523-9. doi: 10.1111/j.1365-2141.2005.05882.x.
6
A novel missense mutation (1060G --> C) in the phosphoglycerate kinase gene in a Japanese boy with chronic haemolytic anaemia, developmental delay and rhabdomyolysis.一名患有慢性溶血性贫血、发育迟缓及横纹肌溶解症的日本男孩,其磷酸甘油酸激酶基因中存在一种新的错义突变(1060G --> C)。
Br J Haematol. 2003 Sep;122(6):1009-13. doi: 10.1046/j.1365-2141.2003.04543.x.
7
Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation.磷酸甘油酸激酶缺乏症:一种具有新突变的成人肌病形式。
Neurology. 2000 Mar 14;54(5):1188-90. doi: 10.1212/wnl.54.5.1188.
8
Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes: PGK Créteil and PGK Amiens.
Blood. 1994 Aug 1;84(3):898-903.
9
Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred.
Br J Haematol. 1995 Sep;91(1):60-5. doi: 10.1111/j.1365-2141.1995.tb05245.x.
10
A new case of phosphoglycerate kinase deficiency: PGK Creteil associated with rhabdomyolysis and lacking hemolytic anemia.
Blood. 1982 Jul;60(1):84-91.